Synthetic Genomics Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Synthetic Genomics Inc.
Venter's Synthetic Genomics Sued For Gender Discrimination
Synthetic Genomics, co-founded by genomic pioneer Craig Venter, has been sued by its former intellectual property chief for gender discrimination – a claim that CEO Oliver Fetzer believes to be "without merit."
Appointments: Sanofi, Regeneron, Galena, Genmab, Abpro and Myokardia
This week's roundup sees Sanofi appoint Biogen's former SVP of corporate affairs to executive vice president, external affairs. Meanwhile, Galena Biopharma, Abpro, Genmab and Purdue Pharma have all named new executives.
Synthetic Biology And The Computerization Of Drug Development
Synthetic biology offers opportunity across many industries, but the ultimate prize may be health care. The millions of dollars investors have poured into companies developing CAR-T cell therapies and gene editing technologies points to growing confidence in the power of gene manipulation to generate novel, approvable therapeutics, even if for now these are just the early steps toward creating fully synthetic organisms.
Execs On The Move, December 2014
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
- Gene Therapy, Cell Therapy
Drug Discovery Tools
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.